In gastric cancer, the expression of AKT in the cytoplasm is significantly increased in patients with phosphatidylinositol-4, 5-bisphosphonate 3-kinase catalytic subunit (PIK3CA) mutation [39]. This evidence concerns the gene AKT1 and gastric cancer.